Predict your next investment

Venture Capital
brandoncapital.com.au

See what CB Insights has to offer

Investments

43

Portfolio Exits

3

Funds

7

About Brandon Capital Partners

Brandon Capital Partners makes seed and venture capital investments to support the development and international growth of Australian life science companies. The firm works collaboratively with entrepreneurs to demonstrate the benefit of their technology, thereby creating value for them, their teams and investors.

Brandon Capital Partners Headquarter Location

Level 1 257 Collins Street

Melbourne, Victoria, 3000,

Australia

+61 3 9657 0700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Brandon Capital Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Brandon Capital Partners in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Brandon Capital Partners News

Allay Therapeutics Completes $60M Series C

Sep 16, 2021

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the completion of its oversubscribed $60M Series C financing, led by Arboretum Ventures. Participating in the round were NEA, Temasek, Pavilion Capital, Brandon Capital Partners, Vertex Growth, Vertex Ventures HC, and WTT Investment Ltd. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Brandon Capital Partners Investments

43 Investments

Brandon Capital Partners has made 43 investments. Their latest investment was in Allay Therapeutics as part of their Series C on September 9, 2021.

CBI Logo

Brandon Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/15/2021

Series C

Allay Therapeutics

$60M

Yes

6

7/13/2021

Seed VC

Amaroq Therapeutics

$9.7M

Yes

1

6/30/2021

Series A

Currus Biologics

$7.5M

Yes

3

6/16/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

11/16/2020

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/15/2021

7/13/2021

6/30/2021

6/16/2021

11/16/2020

Round

Series C

Seed VC

Series A

Seed VC - II

Seed VC

Company

Allay Therapeutics

Amaroq Therapeutics

Currus Biologics

Subscribe to see more

Subscribe to see more

Amount

$60M

$9.7M

$7.5M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

1

3

10

10

Brandon Capital Partners Portfolio Exits

3 Portfolio Exits

Brandon Capital Partners has 3 portfolio exits. Their latest portfolio exit was Elastagen on February 07, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/7/2018

Acquired

$991

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

2/7/2018

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Brandon Capital Partners Fund History

7 Fund Histories

Brandon Capital Partners has 7 funds, including MRCF5.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/29/2019

MRCF5

$147.67M

2

7/26/2016

Medical Research Commercialization Fund III

Subscribe to see more

$99M

10

5/20/2015

Medical Research Commercialisation Fund III

Subscribe to see more

$99M

10

6/30/2012

MRCF IIF Partnership LP

Subscribe to see more

$99M

10

6/30/2009

Brandon Biosciences Fund No 1

Subscribe to see more

$99M

10

Closing Date

4/29/2019

7/26/2016

5/20/2015

6/30/2012

6/30/2009

Fund

MRCF5

Medical Research Commercialization Fund III

Medical Research Commercialisation Fund III

MRCF IIF Partnership LP

Brandon Biosciences Fund No 1

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$147.67M

$99M

$99M

$99M

$99M

Sources

2

10

10

10

10

Brandon Capital Partners Team

5 Team Members

Brandon Capital Partners has 5 team members, including current Chief Financial Officer, Kerensa Argyriou.

Name

Work History

Title

Status

Kerensa Argyriou

Helmsman Capital

Chief Financial Officer

Current

Michael Ball

Chief Financial Officer

Current

David Fisher

Founding Partner

Current

Stephen Thompson

Founding Partner

Current

Chris Nave

Melbourne Ventures

Managing Director

Current

Name

Kerensa Argyriou

Michael Ball

David Fisher

Stephen Thompson

Chris Nave

Work History

Helmsman Capital

Melbourne Ventures

Title

Chief Financial Officer

Chief Financial Officer

Founding Partner

Founding Partner

Managing Director

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.